Pub Date : 2025-10-01Epub Date: 2025-08-22DOI: 10.1016/j.siny.2025.101656
Adriana Dekirmendjian , Fabian Doktor , Lina Antounians , Augusto Zani
Congenital diaphragmatic hernia (CDH) is characterized by pulmonary hypoplasia. CDH lungs exhibit an inflammatory signature with impaired growth, maturation, and vascularization, which postnatally result in altered gas exchange and pulmonary hypertension. These pulmonary abnormalities are drivers of poor survival and long-term morbidity. Improving lung development before birth remains a key strategy to enhance outcomes, and several antenatal therapies have emerged to address this need. These include surgical procedures, pharmacologic agents, and regenerative approaches. Fetal Endoluminal Tracheal Occlusion has shown the most robust evidence, improving survival in selected CDH cases. However, concerns about its generalizability, complications, and its limited effect on overall lung development have underscored the need for complementary or alternative strategies. A wide range of pharmacologic agents, some of which are in clinical use while others remain experimental, has been studied in experimental CDH models, such as corticosteroids, anti-inflammatory drugs and vasoactive medications. In parallel, regenerative medicine strategies via the antenatal administration of stem cells or their derivatives (extracellular vesicles) offer promise through multi-targeted mechanisms that address several aspects of pulmonary hypoplasia. Encouraging preclinical results provide a promising basis for advancing these regenerative therapies toward clinical application, with ongoing investigations focused on establishing their safety, efficacy, and feasibility.
{"title":"Fetal therapies in congenital diaphragmatic hernia: a review of possibilities and practical challenges","authors":"Adriana Dekirmendjian , Fabian Doktor , Lina Antounians , Augusto Zani","doi":"10.1016/j.siny.2025.101656","DOIUrl":"10.1016/j.siny.2025.101656","url":null,"abstract":"<div><div>Congenital diaphragmatic hernia (CDH) is characterized by pulmonary hypoplasia. CDH lungs exhibit an inflammatory signature with impaired growth, maturation, and vascularization, which postnatally result in altered gas exchange and pulmonary hypertension. These pulmonary abnormalities are drivers of poor survival and long-term morbidity. Improving lung development before birth remains a key strategy to enhance outcomes, and several antenatal therapies have emerged to address this need. These include surgical procedures, pharmacologic agents, and regenerative approaches. Fetal Endoluminal Tracheal Occlusion has shown the most robust evidence, improving survival in selected CDH cases. However, concerns about its generalizability, complications, and its limited effect on overall lung development have underscored the need for complementary or alternative strategies. A wide range of pharmacologic agents, some of which are in clinical use while others remain experimental, has been studied in experimental CDH models, such as corticosteroids, anti-inflammatory drugs and vasoactive medications. In parallel, regenerative medicine strategies via the antenatal administration of stem cells or their derivatives (extracellular vesicles) offer promise through multi-targeted mechanisms that address several aspects of pulmonary hypoplasia. Encouraging preclinical results provide a promising basis for advancing these regenerative therapies toward clinical application, with ongoing investigations focused on establishing their safety, efficacy, and feasibility.</div></div>","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"30 3","pages":"Article 101656"},"PeriodicalIF":2.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144976394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01Epub Date: 2025-07-10DOI: 10.1016/j.siny.2025.101653
S. Kamphuis Lieke , M. Schnater Johannes , C.W. Spaander Manon , IJsselstijn Hanneke
For children who have undergone surgical and neonatal intensive care treatment for congenital diaphragmatic hernia (CDH), health care providers’ concerns have shifted from survival rates to the management of associated morbidities. In recent decades, an increasing number of children born with CDH have reached adulthood. Although long-term outcome data remain limited, available evidence suggests that lifelong, multidisciplinary care is necessary across multiple healthcare domains. Moreover, the natural course of many associated morbidities remains poorly understood. This review explores the outcomes of CDH survivors during childhood and young adulthood – periods in which complications often become more evident – and underscores the importance of lifelong care. It also addresses the challenges associated with transitional care programs for adolescents living with chronic health conditions. Finally, the review offers recommendations for designing effective services that support children born with CDH throughout their lifespan.
{"title":"Transitioning to adulthood in congenital diaphragmatic hernia, how do we design the right services?","authors":"S. Kamphuis Lieke , M. Schnater Johannes , C.W. Spaander Manon , IJsselstijn Hanneke","doi":"10.1016/j.siny.2025.101653","DOIUrl":"10.1016/j.siny.2025.101653","url":null,"abstract":"<div><div>For children who have undergone surgical and neonatal intensive care treatment for congenital diaphragmatic hernia (CDH), health care providers’ concerns have shifted from survival rates to the management of associated morbidities. In recent decades, an increasing number of children born with CDH have reached adulthood. Although long-term outcome data remain limited, available evidence suggests that lifelong, multidisciplinary care is necessary across multiple healthcare domains. Moreover, the natural course of many associated morbidities remains poorly understood. This review explores the outcomes of CDH survivors during childhood and young adulthood – periods in which complications often become more evident – and underscores the importance of lifelong care. It also addresses the challenges associated with transitional care programs for adolescents living with chronic health conditions. Finally, the review offers recommendations for designing effective services that support children born with CDH throughout their lifespan.</div></div>","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"30 3","pages":"Article 101653"},"PeriodicalIF":2.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144676338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01Epub Date: 2025-07-01DOI: 10.1016/j.siny.2025.101648
Carmen Mesas Burgos , Erin E. Perrone , Katrin Zahn , Holly L. Hedrick
Congenital diaphragmatic hernia (CDH) is a rare yet serious congenital condition marked by a diaphragmatic defect, pulmonary hypoplasia, and often pulmonary hypertension. While surgical repair is essential for survival, many controversies remain regarding its timing, approach, and techniques.
Delayed repair after physiological stabilization is the current standard, though optimal timing varies. Earlier repair within 24–48 h may reduce hospital stay in some cases, while others benefit from extended stabilization. CDH patients on extracorporeal life support (ECLS) pose additional challenges, balancing bleeding risks against potential survival benefits when surgery is done on ECLS.
Open surgical repair remains the gold standard, especially for large defects, with laparotomy preferred over thoracotomy. Minimally invasive surgery (MIS), although associated with better cosmetic and recovery outcomes, has higher recurrence rates and a steep learning curve. MIS is generally suited for smaller defects, though recent experience shows promising outcomes even in complex cases with patch repairs.
Repair technique depends on defect size. Primary repair is preferred for small defects, while larger defects require synthetic or biological patches with emphasis on a tension-free repair for all defects. Synthetic patches offer strength but carry infection risks, whereas biological materials may lack durability. Muscle flap techniques offer an alternative, especially for recurrent or large defects.
Recurrence remains a major concern, especially with large defects and patch repairs. Open reoperation is standard for recurrences, with MIS reserved for select cases. Prevention strategies include tension-free repair, appropriate patch choice, and meticulous technique.
Emerging strategies, such as regenerative medicine, composite patches, and tissue engineering, show promise but are not yet widely available. Multicenter research, individualized care, and standardized reporting are essential to optimize outcomes and guide future innovations in CDH management.
{"title":"Challenges and controversies in the surgical management of Congenital Diaphragmatic Hernia","authors":"Carmen Mesas Burgos , Erin E. Perrone , Katrin Zahn , Holly L. Hedrick","doi":"10.1016/j.siny.2025.101648","DOIUrl":"10.1016/j.siny.2025.101648","url":null,"abstract":"<div><div>Congenital diaphragmatic hernia (CDH) is a rare yet serious congenital condition marked by a diaphragmatic defect, pulmonary hypoplasia, and often pulmonary hypertension. While surgical repair is essential for survival, many controversies remain regarding its timing, approach, and techniques.</div><div>Delayed repair after physiological stabilization is the current standard, though optimal timing varies. Earlier repair within 24–48 h may reduce hospital stay in some cases, while others benefit from extended stabilization. CDH patients on extracorporeal life support (ECLS) pose additional challenges, balancing bleeding risks against potential survival benefits when surgery is done on ECLS.</div><div>Open surgical repair remains the gold standard, especially for large defects, with laparotomy preferred over thoracotomy. Minimally invasive surgery (MIS), although associated with better cosmetic and recovery outcomes, has higher recurrence rates and a steep learning curve. MIS is generally suited for smaller defects, though recent experience shows promising outcomes even in complex cases with patch repairs.</div><div>Repair technique depends on defect size. Primary repair is preferred for small defects, while larger defects require synthetic or biological patches with emphasis on a tension-free repair for all defects. Synthetic patches offer strength but carry infection risks, whereas biological materials may lack durability. Muscle flap techniques offer an alternative, especially for recurrent or large defects.</div><div>Recurrence remains a major concern, especially with large defects and patch repairs. Open reoperation is standard for recurrences, with MIS reserved for select cases. Prevention strategies include tension-free repair, appropriate patch choice, and meticulous technique.</div><div>Emerging strategies, such as regenerative medicine, composite patches, and tissue engineering, show promise but are not yet widely available. Multicenter research, individualized care, and standardized reporting are essential to optimize outcomes and guide future innovations in CDH management.</div></div>","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"30 3","pages":"Article 101648"},"PeriodicalIF":2.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144602098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01Epub Date: 2025-07-15DOI: 10.1016/j.siny.2025.101655
Jessica C. Pollack , Tim Jancelewicz , Yigit S. Guner
Management of congenital diaphragmatic hernia (CDH) varies widely between institutions, and emerging data suggest that these center-specific practices influence patient outcomes. Given the resource-intensive nature of extracorporeal life support (ECLS) and its reliance on multidisciplinary expertise, regional and hospital level factors are likely critical in optimizing outcomes for this high-risk population. This review synthesizes the existing literature on institutional factors contributing to observed differences in outcomes across centers, explores the complexity of center-level variation in CDH management, and describes targeted research and quality improvement initiatives aimed at enhancing outcomes for neonates affected by this condition.
{"title":"In search of “optimal care”: where should congenital diaphragmatic hernia be managed?","authors":"Jessica C. Pollack , Tim Jancelewicz , Yigit S. Guner","doi":"10.1016/j.siny.2025.101655","DOIUrl":"10.1016/j.siny.2025.101655","url":null,"abstract":"<div><div>Management of congenital diaphragmatic hernia (CDH) varies widely between institutions, and emerging data suggest that these center-specific practices influence patient outcomes. Given the resource-intensive nature of extracorporeal life support (ECLS) and its reliance on multidisciplinary expertise, regional and hospital level factors are likely critical in optimizing outcomes for this high-risk population. This review synthesizes the existing literature on institutional factors contributing to observed differences in outcomes across centers, explores the complexity of center-level variation in CDH management, and describes targeted research and quality improvement initiatives aimed at enhancing outcomes for neonates affected by this condition<strong>.</strong></div></div>","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"30 3","pages":"Article 101655"},"PeriodicalIF":2.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144700147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01Epub Date: 2025-09-02DOI: 10.1016/j.siny.2025.101659
Kylie I. Holden , Devin Saljuud , Kevin Johnson , Matthew T. Harting
Infants with congenital diaphragmatic hernia (CDH) face severe pulmonary hypoplasia, pulmonary hypertension, and cardiac dysfunction, making it one of the most challenging neonatal conditions to manage. Advances in extracorporeal life support (ECLS) have the potential to significantly improve outcomes for the most severe infants with CDH. There has been significant evolution in indications, technology, and clinical strategies which have enhanced its role and improved early stabilization, management, and outcomes. While ECLS remains the foundational management strategy for the most challenging and highest-risk CDH patients, there remains no standard, evidence-based, or widely adopted approach, with variability across centers and ongoing equipoise regarding the optimal timing and criteria, highlighting the need for the development of evidence, further understanding, and refined approaches in CDH. In this review, we highlight recent advances and progressive approaches to ECLS in CDH.
{"title":"Optimizing ECLS strategies in the management of congenital diaphragmatic hernia: Recent advances and best practices","authors":"Kylie I. Holden , Devin Saljuud , Kevin Johnson , Matthew T. Harting","doi":"10.1016/j.siny.2025.101659","DOIUrl":"10.1016/j.siny.2025.101659","url":null,"abstract":"<div><div>Infants with congenital diaphragmatic hernia (CDH) face severe pulmonary hypoplasia, pulmonary hypertension, and cardiac dysfunction, making it one of the most challenging neonatal conditions to manage. Advances in extracorporeal life support (ECLS) have the potential to significantly improve outcomes for the most severe infants with CDH. There has been significant evolution in indications, technology, and clinical strategies which have enhanced its role and improved early stabilization, management, and outcomes. While ECLS remains the foundational management strategy for the most challenging and highest-risk CDH patients, there remains no standard, evidence-based, or widely adopted approach, with variability across centers and ongoing equipoise regarding the optimal timing and criteria, highlighting the need for the development of evidence, further understanding, and refined approaches in CDH. In this review, we highlight recent advances and progressive approaches to ECLS in CDH.</div></div>","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"30 3","pages":"Article 101659"},"PeriodicalIF":2.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145058653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01Epub Date: 2025-08-26DOI: 10.1016/j.siny.2025.101658
David McCulley , Florian Kipfmueller , Neil Patel
Advances in clinical care, biomedical research, and health advocacy have significantly improved survival and quality of life across the lifespan. To sustain and accelerate this progress, it is essential to define clear goals for the future. Congenital diaphragmatic hernia (CDH), one of the most common and severe congenital malformations, serves as a model condition where coordinated efforts in clinical care, research, and advocacy have led to important advances in understanding disease mechanisms and improving outcomes. Reflecting on this progress reveals several key themes, including the value of disease modelling, novel therapeutic strategies, and sustained innovation. Achieving a better future for people with CDH will require strategic prioritization of research, engagement of methodological expertise, addressing practical barriers, and promotion of collaboration. We propose that coordinated global efforts—including for example the creation of an international research platform, leveraging technological advances, and raising the visibility of CDH—will empower clinicians, researchers, and the CDH community to drive continued progress.
{"title":"Congenital Diaphragmatic Hernia: what are the priorities for the next 20 years?","authors":"David McCulley , Florian Kipfmueller , Neil Patel","doi":"10.1016/j.siny.2025.101658","DOIUrl":"10.1016/j.siny.2025.101658","url":null,"abstract":"<div><div>Advances in clinical care, biomedical research, and health advocacy have significantly improved survival and quality of life across the lifespan. To sustain and accelerate this progress, it is essential to define clear goals for the future. Congenital diaphragmatic hernia (CDH), one of the most common and severe congenital malformations, serves as a model condition where coordinated efforts in clinical care, research, and advocacy have led to important advances in understanding disease mechanisms and improving outcomes. Reflecting on this progress reveals several key themes, including the value of disease modelling, novel therapeutic strategies, and sustained innovation. Achieving a better future for people with CDH will require strategic prioritization of research, engagement of methodological expertise, addressing practical barriers, and promotion of collaboration. We propose that coordinated global efforts—including for example the creation of an international research platform, leveraging technological advances, and raising the visibility of CDH—will empower clinicians, researchers, and the CDH community to drive continued progress.</div></div>","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"30 3","pages":"Article 101658"},"PeriodicalIF":2.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144976403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01Epub Date: 2025-08-22DOI: 10.1016/j.siny.2025.101657
María V. Fraga , Gabriel Altit , Bradley A. Yoder , Shazia Bhombal
Congenital diaphragmatic hernia (CDH) is associated with high neonatal morbidity and mortality, often due to complex cardiovascular physiology and ventricular dysfunction. Echocardiography is a critical tool for assessing cardiac anatomy, ventricular performance, pulmonary hypertension, and shunt dynamics in both the prenatal and postnatal periods. Early echocardiographic evaluation can identify high-risk physiologic phenotypes and guide targeted interventions, yet optimal timing and frequency remain uncertain. This review outlines the role of fetal and neonatal echocardiography in CDH, highlights view-specific imaging strategies, and discusses key physiologic patterns. While early imaging may inform management, it must be interpreted in context to avoid unnecessary interventions. A targeted, phenotype-driven approach to echocardiography can support individualized care. Further research is needed to establish standardized protocols and determine the impact of echocardiographic timing on outcomes in this vulnerable population.
{"title":"What is the role of echocardiography in newborns with CDH?","authors":"María V. Fraga , Gabriel Altit , Bradley A. Yoder , Shazia Bhombal","doi":"10.1016/j.siny.2025.101657","DOIUrl":"10.1016/j.siny.2025.101657","url":null,"abstract":"<div><div>Congenital diaphragmatic hernia (CDH) is associated with high neonatal morbidity and mortality, often due to complex cardiovascular physiology and ventricular dysfunction. Echocardiography is a critical tool for assessing cardiac anatomy, ventricular performance, pulmonary hypertension, and shunt dynamics in both the prenatal and postnatal periods. Early echocardiographic evaluation can identify high-risk physiologic phenotypes and guide targeted interventions, yet optimal timing and frequency remain uncertain. This review outlines the role of fetal and neonatal echocardiography in CDH, highlights view-specific imaging strategies, and discusses key physiologic patterns. While early imaging may inform management, it must be interpreted in context to avoid unnecessary interventions. A targeted, phenotype-driven approach to echocardiography can support individualized care. Further research is needed to establish standardized protocols and determine the impact of echocardiographic timing on outcomes in this vulnerable population.</div></div>","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"30 3","pages":"Article 101657"},"PeriodicalIF":2.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144976423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01Epub Date: 2025-07-01DOI: 10.1016/j.siny.2025.101649
Deepika Sankaran , Satyan Lakshminrusimha , Michelle J. Lim
Congenital diaphragmatic hernia (CDH) is a rare congenital anomaly that occurs due to incomplete closure of the diaphragm followed by herniation of abdominal contents into the chest. Fetal hemodynamics are altered in CDH due to pulmonary alveolar and vascular hypoplasia, low pulmonary venous return and in some cases, hypoplasia or dysfunction of the left heart. CDH is associated with high risk of morbidity and mortality due to pulmonary hypoplasia and persistent pulmonary hypertension of the newborn secondary to pulmonary vascular hypoplasia and remodeling. Resuscitation in the delivery room involves optimizing cardiopulmonary transition from fetal to neonatal circulation through gentle ventilation, endotracheal intubation and gastric decompression. Infants with CDH often present with hypoxemic respiratory failure in the immediate postnatal period due to pulmonary hypertension. The understanding of critical cardiopulmonary interactions and the distinguishing features of CDH sub-phenotypes and degree of cardiac involvement may aid in an augmented precision-based approach to invasive ventilation, vasoactive use, and ECMO management. Improved survival is reported after fetal in-utero interventions such as fetoscopic endoluminal tracheal occlusion (FETO) with CDH and severe secondary pulmonary hypoplasia. Clinical outcomes can potentially be improved by optimizing cardiopulmonary transition in the delivery room and cardiopulmonary interactions in the immediate the postnatal period.
{"title":"Cardiorespiratory transition in CDH","authors":"Deepika Sankaran , Satyan Lakshminrusimha , Michelle J. Lim","doi":"10.1016/j.siny.2025.101649","DOIUrl":"10.1016/j.siny.2025.101649","url":null,"abstract":"<div><div>Congenital diaphragmatic hernia<span><span> (CDH) is a rare congenital anomaly that occurs due to incomplete closure of the diaphragm followed by herniation of abdominal contents into the chest. Fetal </span>hemodynamics<span><span><span><span> are altered in CDH due to pulmonary alveolar and vascular hypoplasia<span>, low pulmonary venous return and in some cases, hypoplasia or dysfunction of the left heart. CDH is associated with high risk of morbidity and mortality due to </span></span>pulmonary hypoplasia and </span>persistent pulmonary hypertension<span> of the newborn secondary to pulmonary vascular hypoplasia and remodeling. Resuscitation in the delivery room involves optimizing cardiopulmonary transition from fetal to neonatal circulation through gentle ventilation, </span></span>endotracheal intubation<span><span><span> and gastric decompression. Infants with CDH often present with hypoxemic respiratory failure in the immediate postnatal period due to pulmonary hypertension. The understanding of critical cardiopulmonary interactions and the distinguishing features of CDH sub-phenotypes and degree of cardiac involvement may aid in an augmented precision-based approach to </span>invasive ventilation, vasoactive use, and </span>ECMO management. Improved survival is reported after fetal in-utero interventions such as fetoscopic endoluminal tracheal occlusion (FETO) with CDH and severe secondary pulmonary hypoplasia. Clinical outcomes can potentially be improved by optimizing cardiopulmonary transition in the delivery room and cardiopulmonary interactions in the immediate the postnatal period.</span></span></span></div></div>","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"30 3","pages":"Article 101649"},"PeriodicalIF":2.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144565363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01Epub Date: 2025-07-01DOI: 10.1016/j.siny.2025.101650
Ulla Lei Larsen , John T. Wren Jr. , Christy Gilcrease , Mark Bremholm Ellebaek , Patrick E. Sloan
Survival for infants with congenital diaphragmatic hernia (CDH) has improved, but they continue to face significant nutritional morbidity. They are at risk of growth failure, malnutrition, gastroesophageal reflux disease (GERD), oral aversion, and the need for nutritional tube feeding support after the initial hospitalization. Malnutrition and poor nutritional outcomes impact neurodevelopment, underlining the importance of addressing these issues. Available evidence in this area is scarce, and controversies remain about the timing and mode of enteral feeding in the peri-operative period, the role of enteral nutrition on extracorporeal membrane oxygenation (ECMO), and nutritional growth targets for infants with CDH.
In this manuscript, we discuss enteral and parenteral targets for infants with CDH, growth targets, the timing and advancement of enteral feeding. In addition, we discuss post-discharge nutritional support, identify gaps in the current literature and address parental concerns around nutrition and growth in infants with CDH.
{"title":"Nutrition in congenital diaphragmatic hernia: How and when?","authors":"Ulla Lei Larsen , John T. Wren Jr. , Christy Gilcrease , Mark Bremholm Ellebaek , Patrick E. Sloan","doi":"10.1016/j.siny.2025.101650","DOIUrl":"10.1016/j.siny.2025.101650","url":null,"abstract":"<div><div>Survival for infants with congenital diaphragmatic hernia<span><span> (CDH) has improved, but they continue to face significant nutritional morbidity. They are at risk of growth failure, malnutrition, gastroesophageal reflux disease<span><span><span> (GERD), oral aversion, and the need for nutritional tube feeding support after the initial hospitalization. Malnutrition and poor nutritional outcomes impact </span>neurodevelopment, underlining the importance of addressing these issues. Available evidence in this area is scarce, and controversies remain about the timing and mode of </span>enteral feeding in the peri-operative period, the role of enteral nutrition on </span></span>extracorporeal membrane oxygenation (ECMO), and nutritional growth targets for infants with CDH.</span></div><div>In this manuscript, we discuss enteral and parenteral targets for infants with CDH, growth targets, the timing and advancement of enteral feeding. In addition, we discuss post-discharge nutritional support, identify gaps in the current literature and address parental concerns around nutrition and growth in infants with CDH.</div></div>","PeriodicalId":49547,"journal":{"name":"Seminars in Fetal & Neonatal Medicine","volume":"30 3","pages":"Article 101650"},"PeriodicalIF":2.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144565364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}